By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


REPLICor Inc. 

1550 Metcalfe Street, Suite 502

Montreal  Quebec  H3A1X6  Canada
Phone: 514-842-9849 Fax: 514-842-1505


Company News
REPLICor Inc. Announces Initiation Of Recruitment For Its Phase IIb Clinical Trial With REP 2139-Mg Or REP 2165-Mg In Combination With Viread And Pegasys Or Zadaxin In Patients With Hbeag Negative Chronic Hepatitis B Infection 10/5/2015 10:51:02 AM
REPLICor Inc. To Participate At The 6th DIA / FDA Oligonucleotide-Based Therapeutics Conference 9/3/2015 10:10:49 AM
REPLICor Inc. To Participate In The Jefferies and Co. Hepatitis B Summit In Boston 7/28/2015 10:31:53 AM
REPLICor Inc. Discloses Updated Clinical Trial Data To The Global Virus Hepatitis Summit In Berlin 6/30/2015 12:03:09 PM
REPLICor Inc. To Present At The Israel Association For The Study Of Liver Conference And The Global Virus Hepatitis Summit In Berlin In June 6/10/2015 10:52:34 AM
REPLICor Inc. Release: Significant Reduction Of HBsAg And HDV RNA By REP 2139-Ca In Caucasian Patients With HBV / HDV Co-Infection 4/29/2015 10:01:40 AM
REPLICor Inc. Announces Four Appointments To Scientific Advisory Board 4/27/2015 1:36:16 PM
REPLICor Inc. To Present At The 2015 Lancet Viral Hepatitis Conference 4/10/2015 11:28:08 AM
REPLICor Inc. To Present Updated Clinical Trial Data With Combination Treatment Using Its HBsAg-Release Inhibitors In Patients With Chronic Hepatitis B Infection At The 10th Annual Meeting Of The Oligonucleotide Therapeutics Society (OTS) 10/8/2014 7:54:03 AM
REPLICor's Antiviral Drug Is Active Against H5N1 Avian Flu 4/5/2006 10:38:24 AM